Skip to search formSkip to main contentSkip to account menu

Injection, gadobenate dimeglumine (multihance multipack), per ml

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Cumulative administrations of gadolinium-based contrast agents: risks of accumulation and toxicity of linear vs macrocyclic agents
Abstract Ever since gadolinium was found to deposit in the brain of patients with normal kidney function by Kanda et al. in 2014… 
2018
2018
Non‐clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance®) to neonatal and juvenile rats
2017
2017
A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid
BackgroundCardiac amyloidosis is a progressive but underdiagnosed and underappreciated cause of heart failure. In the last few… 
2015
2015
Compensatory biliary and urinary excretion of gadobenate ion after administration of gadobenate dimeglumine (MultiHance®) in cases of impaired hepatic or renal function: a mechanism that may aid in…
Objective: To determine whether increased elimination of gadobenate ion via the hepatobiliary pathway might compensate for… 
2015
2015
Comparison of gadofosveset (Vasovist(®)) with gadobenate dimeglumine (Multihance(®))-enhanced MR angiography for high-grade carotid artery stenosis.
2011
2011
Ocular Pharmacokinetic Study Using T1 Mapping and Gd-Chelate- Labeled Polymers
ABSTRACTPurposeRecent advances in drug discovery have led to the development of a number of therapeutic macromolecules for… 
2008
2008
Prospective, intraindividual comparison of MRI versus MDCT for endoleak detection after endovascular repair of abdominal aortic aneurysms
This study compares MRI and MDCT for endoleak detection after endovascular repair of abdominal aortic aneurysms (EVAR). Forty… 
Review
2003
Review
2003
Gadobenate dimeglumine (MultiHance®) for magnetic resonance angiography: review of literature
SummaryAlthough limited in number, reports describing the use of Gd-BOPTA for 3D CE-MRA reveal that this agent is safe, well… 
2002
2002
Vergleich von MultiHance® und Gadovist® zur zerebralen MR-Perfusionsmessung bei gesunden Probanden
ZusammenfassungZur Evaluierung des gering proteinbindenden MR-Kontrastmittels MultiHance® und des einmolaren MR-Kontrastmittels… 
2002
2002
Comparison of Gd-BOPTA and Gd-DOTA for peripheral CE-MRA: a double-blind clinical study.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License